CARA FIRCH: Open Payments
NPI 1730585514 · STERLING, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,011 in 120 payments from 10 companies in 2025. Trend: 2023 $1,358 · 2024 $1,604 · 2025 $2,011
Food & beverage: $1,891Education: $120
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 40 | $749 |
| Madrigal Pharmaceuticals | 13 | $303 |
| ABBVIE INC. | 26 | $271 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $192 |
| Aimmune Therapeutics, Inc. | 14 | $179 |
| Gilead Sciences, Inc. | 6 | $110 |
| Ipsen Biopharmaceuticals, Inc | 4 | $106 |
| Lilly USA, LLC | 2 | $44 |
| Phathom Pharmaceuticals, Inc. | 4 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
Products named: TREMFYA, REZDIFFRA, XIFAXAN, ZENPEP, RINVOQ, IQIRVO, SKYRIZI, MAVYRET.
Industry payments across IL — which companies pay providers there.
